Meinhard F. Schmidt Appointed Chairman of the Diabeloop Board

Monday, April 19, 2021

Meinhard F. SchmidtDiabeloop has appointed Meinhard F. Schmidt as its new non-executive chairman. Mr. Schmidt, a healthcare executive and entrepreneur with more than 25 years of international experience in the healthcare, diagnostics and medical devices industries, succeeds Dr. Guillaume Charpentier, who founded Diabeloop in 2015 and has held the position of Chairman since then.

“We are delighted to welcome Meinhard to the Board during this exciting time for Diabeloop,” says Erik Huneker, Diabeloop’s CEO. “With more than 25 years of experience in the global healthcare, diagnostics and medical device sector, he brings an invaluable international, industry, and corporate knowledge to the Company.”

Diabeloop is working on the european commercial deployment of its first product, the DBLG1TM System, an integrated device for autonomous diabetes management. The company is working on obtaining reimbursement agreements in France and Germany. The company, which is currently finalizing a second funding round, also plans to apply for FDA approval in the near future.

After Dr. Guillaume Charpentier stepped down as chairman of the board, Mr. Schmidt assumed this position on June 18, 2019. Dr. Charpentier will remain a member of the Board and Diabeloop Chief Medical Officer.

Dr. Guillaume Charpentier explains: “Bringing a project from an academic prototype to a marketed medical device that will have significant impact on patients’ lives, in less than 4 years, is a tremendous accomplishment for the Diabeloop team and its partners, the CEA-Leti* and the CERITD**. An ambitious task now awaits us to make this innovation available to all families living with Type One diabetes. Meinhard will help us through the next stages of our  development, to achieve our  ambitions.”

Meinhard F. Schmidt adds: “I was drawn to Diabeloop because it has all the hallmarks of a successful, commercial digital health company, including novel technology with the most advanced and promising closed-loop system. Diabeloop introduces an active intelligence layer in the traditional value chain of medical devices for diabetes treatment – something I was looking for since my 20 years of active engagement in the Diabetes Care industry. It’s a privilege to be joining the team at this important time and I am very excited about Diabeloop’s future and the difference we can make at a key phase of our transformation from a company focused on product development, to a full global acting commercial enterprise.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.